Xinhua Silk Road: Enterprise in E. China's Shandong Weihai dedicated to American ginseng products dev't

June 05, 2024 01:16 PM AEST | By Cision

Google News:

Xinhua Silk Road: Enterprise in E. China's Shandong Weihai dedicated to American ginseng products dev't — Image source: Kalkine Media

Recent News

Capillary Technologies Acquires Kognitiv, Strengthening Global Leaders...

Leadership Change at Orora’s Glass Division Amid Strategic Adjustments...

ASX Poised for Pullback Amid Global Market Hesitation; Key Updates fro...

Tech Strength Cushions Broader Weakness as ASX 200 Faces Pullback

BEIJING, June 5, 2024 /PRNewswire/ -- In the workshops of Shandong Yiyang Biotechnology Co., Ltd. (Yiyang Biotechnology) in Weihai City, east China's Shandong Province, four new intelligent production lines recently were busy producing various types of American ginseng products, which were later sent to provinces like Guangdong and Zhejiang after sterilization, drying, packaging and other procedures.

Yiyang Biotechnology, established as a subsidiary of Shandong Yiyang Group in 2013, is a leading enterprise in the American ginseng sector in Weihai City. It is mainly engaged in the cultivation of American ginseng, processing of Chinese medicinal herbs, research and production of health food.

For the public, the most common way to use American ginseng is to slice and brew it in water for drinking. Yiyang Biotechnology has more to offer. It has developed over 30 types of American ginseng products, including canned beverages, bottled beverages, American ginseng-contained paste, tablets, tea bags, and wine.

Believing medicine and food homology (MFH), a concept in traditional Chinese medicine (TCM) referring to edible herbal materials can be employed both as food and medicine, is a trend for the development of the health industry, Yiyang Biotechnology began investing in American ginseng production lines as early as 2019 and has built standard production lines.

In November 2023, American ginseng was included in China's MFH catalog. Yiyang Biotechnology promptly started producing related product series. In the first quarter of 2024 alone, it received orders worth more than 10 million yuan, said Liu Wei, deputy general manager of the company.

The company attaches great importance to technological innovation. It worked with the Institute of Biophysics of Chinese Academy of Sciences in 2009 and made a breakthrough in breaking American ginseng cell wall. Compared with traditional processing methods, the new technique increased the absorption rate of nutrients in American ginseng to over 96 percent.

The two partners also overcame the technical challenge of extracting saponin, making it easy to add this effective component of American ginseng to oral liquids, cosmetics and other types of products.

See the original link: https://en.imsilkroad.com/p/340478.html

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.